The Recall Desk

FDA (Drugs) recall action 90359

Walmart Inc recalled 3 products on 2022-06-22

The FDA (Drugs) publishes a recall like this one as 3 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 3 pages.

Products
3
Announced
2022-06-22
Critical
0
Units
3,924

Why these products were recalled

Marketed Without An Unapproved NDA/ANDA: All lots were found to be unapproved drugs based on labeling claims.

Marketed Without An Unapproved NDA/ANDA: Product lot found to be tainted with undeclared diclofenac, an FDA approved nonsteroidal anti-inflammatory drug (NSAID) for the treatment of pain and inflammation.

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

1–3 of 3

  • ModerateFDA (Drugs)··2022-06-22

    Artri King Reforzado con Ortiga Omega 3 Tablets Recalled as Unapproved Drug

    Walmart Inc is recalling Artri King Reforzado con Ortiga Omega 3 Tablets nationwide because the product was marketed as a drug without FDA approval. All lots are affected.

    Product
    Artri King Reforzado con Ortiga Omega 3 Tablets, ORIGINAL, a) 100-count bottles labeled with UPC 7 501031 111190 and UPC 6 09002 40885, and b) 2 pack of 100-count bottles per carton UPC 3 72426 01434
    Category
    Distribution
    0 states
  • ModerateFDA (Drugs)··2022-06-22

    Artri Ajo King Tablets Recalled for Unapproved Drug Claims

    Walmart is recalling all lots of Artri Ajo King Reforzado con Ortiga y Omega 3 Tablets nationwide. The product was marketed without FDA approval based on unapproved labeling claims.

    Product
    Artri Ajo King Reforzado con Ortiga y Omega 3 Tablets, ORIGINAL, 100-count bottles, UPC 7 501031 12705.
    Category
    Distribution
    0 states
  • SevereFDA (Drugs)··2022-06-22

    Artri King Tablets Recalled Due to Undeclared Diclofenac

    Artri King Reforzado con Ortiga Omega 3 Tablets are being recalled for containing undeclared diclofenac and being marketed without FDA approval. The recall affects 1,308 bottles distributed nationwide.

    Product
    Artri King Reforzado con Ortiga Omega 3 Tablets, ORIGINAL, 100-count bottles, Melchor Ocampo No. 55 Local D, Delegacion Xochimilco, C.P. 16800, Mexico, D.F., UPC 7 501031 111190.
    Category
    Distribution
    0 states